Press release
Wet Age-Related Macular Degeneration Market and Epidemiology 2032: Treatment Market, Therapies, Companies, FDA Approvals, Epidemiology and Forecast by DelveInsight | Opthea Limited, Regenxbio, Alkahest, Graybug Vision, Alcon Research, Qilu Pharma, Ltd., K
To Know in detail about the Wet Age-Related Macular Degeneration market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Wet Age-Related Macular Degeneration Market Forecast
https://www.delveinsight.com/sample-request/wet-age-related-macular-degeneration-wet-amd-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Some of the key facts of the Wet Age-Related Macular Degeneration Market Report:
• The Wet Age-Related Macular Degeneration market size is anticipated to grow with a significant CAGR during the study period (2019-2032)
• In December 2023, EyePoint Pharmaceuticals, a pharmaceutical firm headquartered in the United States, has unveiled encouraging top-line findings from the Phase II DAVIO 2 clinical study involving its sustained-release maintenance treatment, EYP-1901. EYP-1901, currently under investigation, holds promise as a potential therapy for addressing wet age-related macular degeneration (wet AMD).
• In the 7MM, there will likely be 51,743,361 instances of age-related macular degeneration overall in 2021. By 2032, these cases are projected to rise due to a number of risk factors, including ageing, improved care, and increased awareness
• In 2021, the United States had the highest prevalence of Age-Related Macular Degeneration cases among the 7MM, with about 17,282,569 cases
• A total of 38,807,521 diagnosed prevalent instances of age-related macular degeneration were discovered to exist in the 7MM in 2021. By 2032, there should be an increase in these cases
• With 588,809 diagnosed cases, Germany had the highest prevalence of wet age-related macular degeneration among the European nations in 2021, followed by France with 372,836 cases. However, Spain had the lowest diagnosed prevalence rate in 2021
• Wet age-related macular degeneration has a dynamic pipeline. Opthea Limited (OPT-302), Alkahest, Inc. (AKST4290), Graybug Vision (Sunitinib Malate), Ribomic USA (RBM-007), Regenxbio (RGX-314), and Outlook Therapeutics (ONS-5010) are important participants. Throughout the anticipated era (2023-2032), these medications are anticipated to hit the market
• Key Wet Age-Related Macular Degeneration Companies: Opthea Limited, Regenxbio, Alkahest, Graybug Vision, Alcon Research, Qilu Pharmaceutical Co., Ltd., Kodiak Sciences Inc, EyePoint Pharmaceuticals, Inc., Laboratorio Elea Phoenix S.A., Sam Chun Dang Pharma, RemeGen Co., Ltd., Ophthotech Corporation, Mabwell, Novartis, Hoffmann-La Roche, Boehringer Ingelheim, Cinnagen, and others
• Key Wet Age-Related Macular Degeneration Therapies: OPT-302, RGX-314, AKST4290, GB-102, Anecortave Acetate 15 mg, Aflibercept, KSI-301, Eyp-1901, ALK4290, Bevacizumab (Lumiere®), SCD411, RC28-E, Zimura, MW02, ranibizumab, Faricimab, BI 144807, Aflibercept, and others
• The Wet Age-Related Macular Degeneration epidemiology based on gender analyzed that prevalence of Dry Age-Related Macular Degeneration is higher than Wet Age-Related Macular Degeneration
• The Wet Age-Related Macular Degeneration market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Wet Age-Related Macular Degeneration pipeline products will significantly revolutionize the Wet Age-Related Macular Degeneration market dynamics.
Wet Age-Related Macular Degeneration Overview
Wet Age-Related Macular Degeneration (Wet AMD) is a chronic eye condition that affects the macula, the central part of the retina responsible for sharp, central vision. It is a progressive disease that can lead to significant vision loss if left untreated.
Get a Free sample for the Wet Age-Related Macular Degeneration Market Report:
https://www.delveinsight.com/report-store/wet-age-related-macular-degeneration-wet-amd-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Wet Age-Related Macular Degeneration Epidemiology
The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.
Wet Age-Related Macular Degeneration Epidemiology Segmentation:
The Wet Age-Related Macular Degeneration market report proffers epidemiological analysis for the study period 2019-2032 in the 7MM segmented into:
• Total Prevalence of Wet Age-Related Macular Degeneration
• Prevalent Cases of Wet Age-Related Macular Degeneration by severity
• Gender-specific Prevalence of Wet Age-Related Macular Degeneration
• Diagnosed Cases of Episodic and Chronic Wet Age-Related Macular Degeneration
Download the report to understand which factors are driving Wet Age-Related Macular Degeneration epidemiology trends @ Wet Age-Related Macular Degeneration Epidemiology Forecast
https://www.delveinsight.com/sample-request/wet-age-related-macular-degeneration-wet-amd-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Wet Age-Related Macular Degeneration Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Wet Age-Related Macular Degeneration market or expected to get launched during the study period. The analysis covers Wet Age-Related Macular Degeneration market uptake by drugs, patient uptake by therapies, and sales of each drug.
Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.
The report also covers the Wet Age-Related Macular Degeneration Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.
Wet Age-Related Macular Degeneration Therapies and Key Companies
• OPT-302: Opthea Limited
• RGX-314: Regenxbio
• AKST4290: Alkahest
• GB-102: Graybug Vision
• Anecortave Acetate 15 mg: Alcon Research
• Aflibercept: Qilu Pharmaceutical Co., Ltd.
• KSI-301: Kodiak Sciences Inc
• Eyp-1901: EyePoint Pharmaceuticals, Inc.
• ALK4290: Alkahest, Inc.
• Bevacizumab (Lumiere®): Laboratorio Elea Phoenix S.A.
• SCD411: Sam Chun Dang Pharma
• RC28-E: RemeGen Co., Ltd.
• Zimura: Ophthotech Corporation
• MW02: Mabwell
• ranibizumab: Novartis
• Faricimab: Hoffmann-La Roche
• BI 144807: Boehringer Ingelheim
• Aflibercept: Cinnagen
Discover more about therapies set to grab major Wet Age-Related Macular Degeneration market share @ Wet Age-Related Macular Degeneration Treatment Market
https://www.delveinsight.com/sample-request/wet-age-related-macular-degeneration-wet-amd-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Wet Age-Related Macular Degeneration Market Drivers
• Increasing prevalence of wet AMD
• Development in the field of gene therapy
• Robust pipeline
• Novel oral formulations for the treatment of wet AMD
Wet Age-Related Macular Degeneration Market Barriers
• High cost of treatment
• Competitive treatment landscape
• Emerging biosimilars
• Low compliance
Scope of the Wet Age-Related Macular Degeneration Market Report
• Study Period: 2019-2032
• Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
• Key Wet Age-Related Macular Degeneration Companies: Opthea Limited, Regenxbio, Alkahest, Graybug Vision, Alcon Research, Qilu Pharmaceutical Co., Ltd., Kodiak Sciences Inc, EyePoint Pharmaceuticals, Inc., Laboratorio Elea Phoenix S.A., Sam Chun Dang Pharma, RemeGen Co., Ltd., Ophthotech Corporation, Mabwell, Novartis, Hoffmann-La Roche, Boehringer Ingelheim, Cinnagen, and others
• Key Wet Age-Related Macular Degeneration Therapies: OPT-302, RGX-314, AKST4290, GB-102, Anecortave Acetate 15 mg, Aflibercept, KSI-301, Eyp-1901, ALK4290, Bevacizumab (Lumiere®), SCD411, RC28-E, Zimura, MW02, ranibizumab, Faricimab, BI 144807, Aflibercept, and others
• Wet Age-Related Macular Degeneration Therapeutic Assessment: Wet Age-Related Macular Degeneration current marketed and Wet Age-Related Macular Degeneration emerging therapies
• Wet Age-Related Macular Degeneration Market Dynamics: Wet Age-Related Macular Degeneration market drivers and Wet Age-Related Macular Degeneration market barriers
• Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
• Wet Age-Related Macular Degeneration Unmet Needs, KOL's views, Analyst's views, Wet Age-Related Macular Degeneration Market Access and Reimbursement
To know more about Wet Age-Related Macular Degeneration companies working in the treatment market, visit @ Wet Age-Related Macular Degeneration Clinical Trials and Therapeutic Assessment
https://www.delveinsight.com/sample-request/wet-age-related-macular-degeneration-wet-amd-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Table of Contents
1. Wet Age-Related Macular Degeneration Market Report Introduction
2. Executive Summary for Wet Age-Related Macular Degeneration
3. SWOT analysis of Wet Age-Related Macular Degeneration
4. Wet Age-Related Macular Degeneration Patient Share (%) Overview at a Glance
5. Wet Age-Related Macular Degeneration Market Overview at a Glance
6. Wet Age-Related Macular Degeneration Disease Background and Overview
7. Wet Age-Related Macular Degeneration Epidemiology and Patient Population
8. Country-Specific Patient Population of Wet Age-Related Macular Degeneration
9. Wet Age-Related Macular Degeneration Current Treatment and Medical Practices
10. Wet Age-Related Macular Degeneration Unmet Needs
11. Wet Age-Related Macular Degeneration Emerging Therapies
12. Wet Age-Related Macular Degeneration Market Outlook
13. Country-Wise Wet Age-Related Macular Degeneration Market Analysis (2019-2032)
14. Wet Age-Related Macular Degeneration Market Access and Reimbursement of Therapies
15. Wet Age-Related Macular Degeneration Market Drivers
16. Wet Age-Related Macular Degeneration Market Barriers
17. Wet Age-Related Macular Degeneration Appendix
18. Wet Age-Related Macular Degeneration Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight
Latest Reports by DelveInsight
Cerebral Palsy Market
https://www.delveinsight.com/report-store/cerebral-palsy-market
DelveInsight's 'Cerebral Palsy Market Insights, Epidemiology, and Market Forecast 2032' report delivers an in-depth understanding of cerebral palsy, historical and forecasted epidemiology as well as cerebral palsy market trends in the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.
Granulomatosis With Polyangiitis Market
https://www.delveinsight.com/report-store/granulomatosis-with-polyangiitis-market
DelveInsight's "Granulomatosis With Polyangiitis Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Granulomatosis With Polyangiitis, historical and forecasted epidemiology as well as the Granulomatosis With Polyangiitis market trends in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom) and Japan.
Hemophilia A Market
https://www.delveinsight.com/report-store/hemophilia-a2030-market
DelveInsight's "Hemophilia A Market Insights, Epidemiology, and Market Forecast - 2034" report delivers an in-depth understanding of the Hemophilia A, historical and forecasted epidemiology as well as the Hemophilia A market trends in the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan.
Graft Versus Host Disease Market https://www.delveinsight.com/report-store/graft-versus-host-disease-gvhd-market
DelveInsight's "Graft Versus Host Disease (GvHD) Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Graft Versus Host Disease, historical and forecasted epidemiology as well as the Graft Versus Host Disease market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Hemorrhoids Market
https://www.delveinsight.com/report-store/hemorrhoids-market
DelveInsight's "Hemorrhoids Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Hemorrhoids, historical and forecasted epidemiology as well as the Hemorrhoids market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Asthma Market
https://www.delveinsight.com/report-store/asthma-market
DelveInsight's "Asthma - Market Insights, Epidemiology, and Market Forecast - 2032" report delivers an in-depth understanding of the disease, historical and forecasted epidemiology as well as the Asthma market trends in the United States, EU4 (Germany, France, Italy, Spain), the United Kingdom, and Japan.
Myelodysplastic Syndrome Market
https://www.delveinsight.com/report-store/myelodysplastic-syndrome-market
DelveInsight's "Myelodysplastic Syndrome Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Myelodysplastic Syndrome, historical and forecasted epidemiology as well as the Myelodysplastic Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom) and Japan.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Gaurav Bora
Email: info@delveinsight.com
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/consulting
About DelveInsight
DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Wet Age-Related Macular Degeneration Market and Epidemiology 2032: Treatment Market, Therapies, Companies, FDA Approvals, Epidemiology and Forecast by DelveInsight | Opthea Limited, Regenxbio, Alkahest, Graybug Vision, Alcon Research, Qilu Pharma, Ltd., K here
News-ID: 3489535 • Views: …
More Releases from DelveInsight Business Research
Amyotrophic Lateral Sclerosis Market Forecast 2034: FDA, EMA, PDMA Approvals, Cl …
Amyotrophic Lateral Sclerosis companies are Biogen, Ionis Pharmaceuticals, Ferrer Internacional S.A., AbbVie, Calico Life Sciences LLC, Genuv Inc., Kadimastem, Corcept Therapeutics, AL-S Pharma, Rapa Therapeutics LLC, Cytokinetics, MediciNova, Retrotope, Inc. Woolsey Pharmaceuticals, Sanofi, PTC Therapeutics, Helixmith Co., Ltd., Annexon, Inc., Denali Therapeutics Inc., Revalesio Corporation, Clene Nanomedicine, Ashvattha Therapeutics, Inc., Apellis Pharmaceuticals, Inc., Procypra Therapeutics, Knopp Biosciences, InFlectis BioScience, AI Therapeutics, Inc., Cellenkos, ZZ Biotech, LLC, QurAlis Corporation, Alector Inc.,…
PD1 and PDL1 Inhibitors Market Forecast 2034: FDA, EMA, PDMA Approvals, Clinical …
(Albany, USA) DelveInsight's PD1 and PDL1 Inhibitors Competitive Landscape report delivers an in-depth understanding of the PD1 and PDL1 inhibitors and the PD1 and PDL1 inhibitors market trends in the 7MM [the United States, the EU-4 (Italy, Spain, France, and Germany), the United Kingdom, and Japan].
Request for sample report to know more about the PD1 and PDL1 Inhibitors market report offerings @ https://www.delveinsight.com/report-store/pd-1-pdl-1-inhibitors-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Key Takeaways from the PD1 and PDL1 Inhibitors…
Heart Failure Pipeline and Clinical Trials Assessment 2024: FDA Approvals, Thera …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Heart Failure pipeline constitutes 75+ key companies continuously working towards developing 90+ Heart Failure treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
"Heart Failure Pipeline Insight, 2024" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Heart Failure Market.
The Heart…
Primary Hyperoxaluria Pipeline and Clinical Trials Assessment: FDA Approvals, Th …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Primary Hyperoxaluria pipeline constitutes 8+ key companies continuously working towards developing 8+ Primary Hyperoxaluria treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
"Primary Hyperoxaluria Pipeline Insight, 2024" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Primary Hyperoxaluria Market.
The Primary…
More Releases for Wet
Global Wet Cat Food Market and Trends
According to a new report published by Allied Market Research, titled, "Wet Cat Food Market by Product Type, End User, and Distribution Channel: Global Opportunity Analysis and Industry Forecast, 2021-2030," The lockdown across various countries and ban on international travel has disrupted the supply chain and revenue chain.
The global wet cat food market size was valued at $4.6 billion in 2020, and is projected to reach $7.9 billion by 2030,…
Oscillation Flowmeters for Dry and Wet Gases
Oscillation is a measurement method that is unique for gases and can be used in a variety of ways for flow measurement with the aid of a flow oscillator. With this unique measuring method, a partial flow of the medium is passed through a bypass into the oscillator. In the oscillator, the medium flows through a chamber with two flow channels. A bluff body deflects the flow either in one…
Emirates Wet Wipes Partners with Medialinks
Emirates Wet Wipes, one of the largest hygiene care products manufacturers in the GCC, is ramping up its advertising and brand direction with the appointment of integrated digital & ecommerce agency, Medialinks, to its pan-Arab business.
Medialinks will be EWW’s first retained agency to oversee company’s entire digital account, which will encompass a fully optimized website, advertising, social, search engine optimisation and analytics.
The appointment happened after three-month competitive pitch process.…
Cross Fold Wet Tissue Market|| Worldwide, 2030
The “Cross Fold Wet Tissue Market Analysis to 2030” is a specialized and in-depth study of the Cross Fold Wet Tissue industry with a focus on the Cross Fold Wet Tissue market trend. The report aims to provide an overview of the Cross Fold Wet Tissue market with detailed market segmentation by component, application, end-user, and geography. The Cross Fold Wet Tissue market is expected to witness high growth during…
Global Cat Wet Food Market 2017 - NORY, WIK, Wanpy, Nature Bridge, WET NOSES
Apex Research, recently published a detailed market research study focused on the "Cat Wet Food Market" across the global, regional and country level. The report provides 360° analysis of "Cat Wet Food Market" from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global Cat Wet Food industry, and estimates the future trend of Cat…
Emerging Opportunities in Wet Macular Degeneration Market
Wet Macular Degeneration Market: Overview
Macular degeneration is a weakening or collapsed working of the eyes’ macula. Macula is the small area on the retinal surface covered by the light-sensitive tissue lining which is blackish area of the eye. This part of the retina is responsible for individual’s central vision, allows viewing fine objects clearly. Generally old aged people develop macular degeneration because of natural aging process of the body. There…
